AMRX
Amneal Pharmaceuticals, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum inputs (comparable managers):
holder breadth -6.2% ·
share flow +3.0% ·
net new positions -6.7%
— formula
Concentrated accumulation — rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 101 | -4 | 106.56M | $1.84B | +7 | −10 |
| Q1 2026 | 107 | -1 | 100.53M | $1.25B | +9 | −11 |
| Q4 2025 | 109 | 0 | 106.30M | $1.34B | +1 | — |
| Q3 2025 | 18 | 0 | 61.16M | $612.26M | — | — |
| Q2 2025 | 15 | -1 | 52.63M | $425.79M | — | −1 |
| Q1 2025 | 13 | +3 | 21.14M | $177.14M | +3 | — |
| Q4 2024 | 10 | -1 | 20.64M | $163.48M | — | −1 |
| Q3 2024 | 10 | 0 | 16.87M | $140.36M | +2 | −2 |
| Q2 2024 | 10 | — | 16.56M | $105.19M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passive) | 17.55M | — | $141.99M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | The Vanguard Group ✦ (passive) | 17.55M | — | $141.99M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | The Vanguard Group ✦ (passive) | 17.55M | — | $141.99M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | The Vanguard Group ✦ (passive) | 17.55M | — | $141.99M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | The Vanguard Group ✦ (passive) | 17.55M | — | $141.99M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passive) | 12.13M | — | $98.14M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passive) | 12.13M | — | $98.14M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passive) | 12.13M | — | $98.14M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passive) | 12.13M | — | $98.14M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passive) | 12.13M | — | $98.14M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passive) | 12.13M | — | $98.14M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passive) | 12.13M | — | $98.14M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passive) | 12.13M | — | $98.14M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passive) | 12.13M | — | $98.14M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passive) | 12.13M | — | $98.14M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passive) | 12.13M | — | $98.14M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (passive) | 12.13M | — | $98.14M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (passive) | 12.13M | — | $98.14M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (passive) | 12.13M | — | $98.14M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Citadel Advisors ✦ | 5.62M | -24.9% | $45.50M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 21 | Citadel Advisors ✦ | 5.62M | -24.9% | $45.50M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 22 | Millennium Management ✦ | 5.04M | +141.6% | $40.80M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 23 | State Street Global Advisors ✦ (passive) | 3.92M | +6.1% | $31.68M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 24 | Geode Capital Management ✦ (passive) | 3.76M | -1.7% | $30.41M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 25 | Geode Capital Management ✦ (passive) | 3.76M | -1.7% | $30.41M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 26 | Arrowstreet Capital ✦ | 1.70M | -5.4% | $13.73M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 27 | AQR Capital Management ✦ | 1.02M | +36.7% | $8.24M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 1.02M | +36.7% | $8.24M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 1.02M | +36.7% | $8.24M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | AQR Capital Management ✦ | 1.02M | +36.7% | $8.24M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | AQR Capital Management ✦ | 1.02M | +36.7% | $8.24M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 32 | D. E. Shaw & Co. ✦ | 923.64K | +5732.6% | $7.47M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 33 | D. E. Shaw & Co. ✦ | 923.64K | +5732.6% | $7.47M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 34 | Renaissance Technologies ✦ | 428.00K | -31.5% | $3.46M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 35 | Fidelity (FMR) ✦ | 263.69K | — | $2.13M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Fidelity (FMR) ✦ | 263.69K | — | $2.13M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | T. Rowe Price ✦ | 130.65K | +3.1% | $1.06M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 38 | Wellington Management ✦ | 65.62K | -6.3% | $530,841 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 39 | Wellington Management ✦ | 65.62K | -6.3% | $530,841 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 40 | Wellington Management ✦ | 65.62K | -6.3% | $530,841 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 41 | Wellington Management ✦ | 65.62K | -6.3% | $530,841 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 42 | Gotham Asset Management ✦ | 60.20K | +14.3% | $487,042 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 43 | Two Sigma Investments ✦ | 17.75K | -89.4% | $143,557 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Point72 Asset Management | $3.74M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 314 holders, 158.91M shares, $1.92B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Director · 50.00K sh · $882,000
Officer · 146.40K sh · $2.56M
Officer · 210.00K sh · $3.65M
Officer · 6.61K sh · $117,050
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology
17.6% of class · View original SEC filing ↗
8.4% of class · View original SEC filing ↗
9.4% of class · View original SEC filing ↗